. 2024 May 29;20(7):4389–4400. doi: 10.1002/alz.13800

TABLE 3.

Frequency of AD CSF profile at baseline and follow‐up in each study subgroup.

	Normotension (n = 130)	Controlled hypertension (n = 34)	Uncontrolled hypertension (n = 32)	P (χ² test)
A+/T+ n (%) (baseline)	10 (8%)	5 (15%)	1 (3%)	0.22
A+/T+ n (%) (follow‐up)	11 (9%)	6 (18%)	4 (13%)	0.29
P value (McNemar test)	1.0	1.0	0.25

Normotension

(n = 130)

Controlled hypertension

(n = 34)

Uncontrolled hypertension

(n = 32)

(χ² test)

A+/T+

n (%) (baseline)

10 (8%)

5 (15%)

1 (3%)

0.22

A+/T+

n (%) (follow‐up)

11 (9%)

6 (18%)

4 (13%)

0.29

P value

(McNemar test)

1.0

0.25

Note: P values in bottom row are given for comparison between baseline and last assessment within subgroups (McNemar test for paired proportions) and in last column to compare frequencies of AD profiles between subgroups at baseline and follow‐up (χ² test).